LY-2334737

DB12906InvestigationalSmall molecule

LY2334737 has been used in trials studying the treatment of Solid Tumor, Metastatic Tumor, and Malignant Solid Tumor.

Chemical structure of LY-2334737
Formula / weight
C17H25F2N3O5 · 389.4 g/mol (avg)
Code names
LY2334737

Resolves to

Compound
UNIIYLR364XYSACAS892128-60-8ChEMBLCHEMBL577711PubChem11646777
Structure
InChIKeyMEOYFIHNRBNEPI-UXIGCNINSA-NSMILESCCCC(CCC)C(=O)NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](CO)[C@@H](O)C1(F)F
Targets
P31350RRM2

What you can answer from here — as of January 29, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
2Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with LY-2334737, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In